Table 1 Demographic characteristics, clinical features, investigations, complications and outcome of study participants

Male

391 (58)

Female

289 (43)

Age in years median (IQR)

5 (2–8)

Place of presentation

 E/R

612 (90)

 OPD

65 (9.6)

 Inpatient

3 (0.4)

Fever

680 (100)

Vomitting

242 (36)

Diarrhea

174 (26)

Anorexia

140 (21)

Cough

126 (19)

Abdominal pain

125 (18)

Hepatomegaly

63 (9)

Splenomegaly

22 (3)

Urinary symptoms

14 (2)

Rash

12 (2)

Bleeding per rectum

4 (1)

Raised CRP > 5 (415)

395 (95)

Hyponatremia (severe + moderate combined) (178)

74 (41)

Acidosis (178)

65 (37)

Hypokalemia (severe + moderate combined) (178)

59 (33)

Severe thrombocytopenia (< 50,000 × 10⁹/L) (676)

24 (4)

Raised serum creatinine (151)

4 (3)

Severe anemia (Hb < 5 gm/dl) (676)

9 (1)

Mesentric lymphadenopathy (on abdominal ultrasound), (62)

11 (18)

Encephalopathy (101)

16 (16)

Hepatitis, LFT (81)

11 (14)

Peritoneal free fluid (on abdominal ultrasound) (62)

8 (13)

Bi-cytopenia (676)

67 (10)

Pleural effusion (on abdominal ultrasound) (62)

6 (10)

Cholecystitis (on abdominal ultrasound) (62)

4 (6)

Shock (seen in 101 admitted patients)

5 (5)

Encephalitis (seen in 101 admitted patients)

4 (4)

Aphasia (seen in 101 admitted patients)

4 (4)

Pancytopenia, done in 676

16 (2)

Patients with known outcomes (270)

 Cured

234 (87)

 Delayed response

32 (12)

 Died

4 (1)

Patients with unknown outcomes (410)

 Lost to follow up

351 (86)

 LAMA/referred out

59 (14)